BRENNEN

Industries / Health / Health insurers and PBMs

Fraud and audits

Finding claims that should not have been paid, from bills for care never given to padded diagnoses, and the outside audits and lawsuits that check the payers and PBMs themselves.

7

Milestones achieved, from 1985 to 2026.

1

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1985

    Insurers and agencies join forces

    Several private health insurers and federal and state officials founded the National Health Care Anti-Fraud Association (NHCAA) in 1985 as a private-public partnership against health care fraud. Its members now include nearly 90 private health insurers and the public agencies that have jurisdiction over health care fraud, and it trains investigators through an institute set up in 2000.

    nhcaa.org

    Credit

    NHCAA's founding insurers and officials

  2. 2004

    Fraud units in every fund

    Since 1 January 2004 German law has required every statutory sickness fund, their associations and the national association to run units that look into signs of irregular or unlawful use of funds, and to report to their boards every two years. The national association's combined report for 2022 and 2023 counted 49,982 tips, losses of over €200 million (€132 million in 2020 and 2021) and about €92 million recovered or secured, with the largest losses, nearly €86 million, in drugs and dressings.

    Lessoneach fund sees only its own bills; the national association says the law stops the funds from pooling billing data to search it with AI.

    dserver.bundestag.degesetze-im-internet.degkv-spitzenverband.de

    Credit

    the Bundestag (law); GKV-Spitzenverband, the national association of sickness funds (combined report)

  3. 2011

    Claims screened before payment

    The US Small Business Jobs Act of 2010 required Medicare to use predictive analytics against fraud. In the first year, from 1 July 2011, CMS reported that its Fraud Prevention System reviewed all Medicare fee-for-service claims nationwide before payment and passed leads to its investigators. The health department's Office of Inspector General (OIG), which the law made certify the savings, could not confirm the first year's figures. For the third year it certified $133.2 million in actual and projected savings, a return of $2.84 per dollar spent, against $454 million the system had identified before adjustment.

    Lessonsavings claimed for a fraud model shrink when an outside auditor checks how they were counted.

    oig.hhs.govoig.hhs.gov

    Credit

    CMS; certification by the HHS OIG

  4. 2021

    A plan's PBM repays states

    Ohio's attorney general sued Centene in March 2021, alleging that its pharmacy benefit subsidiary overbilled Ohio Medicaid and that the company misrepresented the cost of pharmacy services. On 14 June 2021 Centene agreed to pay Ohio $88.3 million, which the attorney general called a record, and Mississippi $55 million, without admitting liability. It set aside $1.1 billion to settle with other states and said its PBM, Envolve, would become an administrative service provider instead.

    ohioattorneygeneral.govsec.gov

    Credit

    Ohio Attorney General Dave Yost; Centene

  5. 2024

    Brokers blocked from switching plans

    Agents and brokers who enroll people in HealthCare.gov plans are paid commissions. From January to August 2024 CMS received 183,553 complaints that people had been enrolled without their consent. From 19 July 2024 it blocked agents from changing an enrollment they were not already linked to, unless the consumer joined a three-way call with the Marketplace call center, and from June to October 2024 it suspended 850 agents and brokers.

    cms.gov

    Credit

    CMS

  6. 2025

    Drug-cost suits fail on standing

    Employees sued Johnson & Johnson and Wells Fargo in 2024, claiming that the employers, as fiduciaries of their health plans, let the plans overpay for drugs; one example was a plan paying far more for a generic multiple sclerosis drug than a cash buyer pays at a large pharmacy. Federal judges dismissed the claims for lack of standing, in New Jersey on 24 January 2025 and in Minnesota on 24 March 2025, finding the harm to employees' premiums and out-of-pocket costs speculative or not shown.

    Lessonan employee suing over a plan's drug costs must show those costs changed what they themselves paid.

    govinfo.govgovinfo.gov

    Credit

    US District Courts for the District of New Jersey (Judge Zahid Quraishi) and the District of Minnesota

  7. 2026

    Gaps in the plans' blocklist

    CMS keeps a Preclusion List of providers whom Medicare Advantage and Part D plans may not pay. The OIG found that plans paid $72 million in 2022 to 2024 to 249 of 1,017 provider numbers that had been revoked from Medicare but were missing from the list. The causes were timing errors, organizations left off when their owners were excluded or convicted, and a rule that exempts pharmacies that only fill prescriptions.

    oig.hhs.gov

    Credit

    HHS OIG, report A-02-24-01013, September 2026

Watch for

  1. Criminal probe of plan billing

    UnitedHealth Group disclosed on 24 July 2025 that it was complying with formal criminal and civil requests from the US Justice Department about aspects of its participation in Medicare, after media reports of investigations. It said it had begun third-party reviews of its risk adjustment coding, managed care and pharmacy practices, and cited a court-appointed Special Master who found no evidence of wrongdoing in an earlier civil case over its Medicare Advantage business.

    Achieved whenthe department files charges, settles or closes the investigation, or UnitedHealth publishes the findings of its third-party reviews.

    sec.gov

    Claimed by

    the US Justice Department's investigation, as disclosed by UnitedHealth Group, July 2025

Open

  1. 01

    Charts that support the diagnosis

    A public test of AI tools that check whether a medical record supports each diagnosis a Medicare Advantage plan reported for payment. Write at least 1,000 invented patient charts, each with the diagnosis codes a plan "submitted" and notes that back some of them and not others. Label each payment condition with the outcomes CMS uses in its risk adjustment data validation (RADV) audits: confirmed, confirmed at a higher or lower level of the same condition group, or not confirmed. Two certified coders label every chart separately. Then score AI tools, and coders working alone, against the labels.

    The brief
    Credit · unclaimed
  2. 02

    What contract definitions cost

    An open calculator that takes one year of invented pharmacy claims for an invented employer plan of 10,000 members and reconciles a PBM's guaranteed discounts and rebates under each common way that contracts define a brand-name, generic or specialty drug and leave claims out of the guarantees, so that the dollar effect of each definition can be seen side by side on the same claims. Each definition is written out as a plain-language model clause with the published source it comes from, and the calculator lists which drugs fall into each class under each clause.

    The brief
    Credit · unclaimed

Open 01 · the brief

Charts that support the diagnosis

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public test of AI tools that check whether a medical record supports each diagnosis a Medicare Advantage plan reported for payment. Write at least 1,000 invented patient charts, each with the diagnosis codes a plan "submitted" and notes that back some of them and not others. Label each payment condition with the outcomes CMS uses in its risk adjustment data validation (RADV) audits: confirmed, confirmed at a higher or lower level of the same condition group, or not confirmed. Two certified coders label every chart separately. Then score AI tools, and coders working alone, against the labels.

Why it is still open

CMS said in May 2025 that it would use technology to flag unsupported diagnoses and grow its team of medical coders from 40 to about 2,000. Plans and vendors sell AI for the same check, but a November 2026 search found only vendor claims, such as an account of one AI tool whose suggested diagnoses providers rejected nearly 70% of the time, and on GitHub only a client for a paid scrubbing service. No public labeled test was found.

cms.govhitconsultant.net

Built with what exists

CMS's published RADV payment error methodology and its table of audit outcomes; Synthea for invented patient histories; an AI model to draft clinic notes that the coders then correct; open-weight models run locally (see the Note "A trillion open parameters") and hosted models; a Python scoring script. Invented patients only, with no real records.

cms.gov

  1. First step

    Write 25 invented charts covering three common payment conditions, such as diabetes with complications, have two coders label them separately, and compare their labels.

  2. Done looks like

    1,000 charts with at least 3,000 labeled conditions, the coders' agreement reported, at least four AI tools scored on conditions wrongly confirmed and wrongly rejected, published with a DOI.

Open 02 · the brief

What contract definitions cost

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

An open calculator that takes one year of invented pharmacy claims for an invented employer plan of 10,000 members and reconciles a PBM's guaranteed discounts and rebates under each common way that contracts define a brand-name, generic or specialty drug and leave claims out of the guarantees, so that the dollar effect of each definition can be seen side by side on the same claims. Each definition is written out as a plain-language model clause with the published source it comes from, and the calculator lists which drugs fall into each class under each clause.

Why it is still open

Milliman, an actuarial firm, writes that the ways PBMs define a generic drug "have become exceedingly complex", that complex definitions are harder to audit, and that PBMs "may be able to change the brand or generic statuses of drugs" to meet the discount guarantees they quoted. From 2028 the Consolidated Appropriations Act, 2026 requires PBMs that serve Medicare drug plans to use clear definitions of generic, brand-name and specialty drugs and of rebates, and lets the plans audit them each year, by a Rice University Baker Institute summary. Consultants publish guides to these terms, but a search in November 2026 found no public tool that prices each definition on the same claims.

us.milliman.combakerinstitute.org

Built with what exists

the FDA's NDC Directory, updated daily, which gives each product's marketing category, and its Orange Book of therapeutic equivalents; CMS's weekly National Average Drug Acquisition Cost (NADAC) file, a public price per unit that CMS calculates separately for brand-name and generic drugs; Synthea or a short script for the invented claims; Python; an AI model to draft clause variants from published guides, each checked by a pharmacist and an actuary.

fda.govfda.govmedicaid.gov

  1. First step

    Take the 1,000 most common products in this week's NADAC file and sort them into brand-name and generic three ways, by FDA marketing category, by Orange Book equivalence and by NADAC's own grouping, then count the products that change class.

  2. Done looks like

    at least eight definitions of a generic drug and five kinds of exclusion clause, each tied to a published source; for each, the number of drugs that change class and the change in the plan's guaranteed discount in dollars on the same invented claims year; the clause library, the class lists and the code published after review by one pharmacist and one actuary.